Curis vs Ryvu Therapeutics
Curis
Working relentlessly to develop innovative and differentiated therapeutics that improve the lives of cancer patients
133 employees · est. 2000 · Lexington, United States
Ryvu Therapeutics
Developing novel treatments at the forefront of oncology
284 employees · est. 2007 · Krakow, Poland
Curis is the older company (2000 vs 2007); Ryvu Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Curis | Ryvu Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2000 older | 2007 |
| Headquarters | ||
| Headquarters | Lexington, United States | Krakow, Poland |
| Employees | ||
| Employees | 133 | 284 larger |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post-IPO Equity | Post-IPO Debt |
| Funding Rounds | ||
| Funding Rounds | 9 | Not tracked yet |
| Taxonomy | ||
| Taxonomy | OncologyDrug DevelopmentImmunologyClinical DevelopmentHematologyTherapeutics +8 | Not tracked yet |
| Website | ||
| Website | curis.com | ryvu.com |
About Curis
Curis, a publicly-traded biotechnology company (NASDAQ: CRIS), focuses on developing first-in-class and innovative therapeutics for cancer treatment. The company has three drug candidates in development: Emavusertib (CA-4948), CI-8993, and Fimepinostat. It also collaborates with Aurigene for immuno-...
About Ryvu Therapeutics
Ryvu Therapeutics is a clinical-stage drug discovery and development company focused on novel small molecule therapies that address emerging targets in oncology. Internally discovered pipeline candidates make use of diverse therapeutic mechanisms driven by emerging knowledge of cancer biology, inc...
Also comparing in this category
Comparing more than these two?
Get Curis, Ryvu Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Curis compare?
A PDF of Curis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Curis with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Curis on 9 Nov 2024, and Ryvu Therapeutics on 28 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
